--- title: "Tesamorelin Research Guide: GHRH Analog Explained" description: "Tesamorelin is a stabilized GHRH analog that raises your own growth hormone and IGF-1. What the visceral-fat and cognition trials actually show." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Blog", "item": "https://www.bodyhackguide.co/blog" }, { "@type": "ListItem", "position": 3, "name": "Tesamorelin: A Complete Research Reference" } ] }, { "@context": "https://schema.org", "@type": "BlogPosting", "headline": "Tesamorelin: A Complete Research Reference", "description": "Tesamorelin is a synthetic, stabilized GHRH analog approved as Egrifta for HIV-associated visceral fat. This guide covers the real trial evidence for visceral fat, liver fat, and cognition, how it differs from CJC-1295 and from GH itself, the approved and studied doses, and how the peptide-research community discusses it, with research-use-only framing throughout.", "image": "https://www.bodyhackguide.co/og-image.png", "datePublished": "2026-07-01T16:25:06.42154+00:00", "dateModified": "2026-09-19T10:10:48.601117+00:00", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/bhglogo.png" } }, "mainEntityOfPage": "https://www.bodyhackguide.co/blog/tesamorelin-research-guide", "wordCount": 2231, "timeRequired": "PT12M", "articleSection": "Peptides", "inLanguage": "en-US", "isAccessibleForFree": true, "speakable": { "@type": "SpeakableSpecification", "cssSelector": [ "h1", ".blog-tldr", "article p:first-of-type" ] } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is tesamorelin and what is it researched for?", "acceptedAnswer": { "@type": "Answer", "text": "Tesamorelin is a synthetic, stabilized analog of growth-hormone-releasing hormone (GHRH). It binds the GHRH receptor on the pituitary and stimulates release of your own growth hormone, which raises IGF-1 [PMID:21668043]. It is FDA-approved as Egrifta to reduce excess visceral abdominal fat in HIV-associated lipodystrophy [PMID:18057338], and it is being researched for broader visceral-fat and body-composition effects, liver fat [PMID:31611038], and cognition in older adults [PMID:22869065]." } }, { "@type": "Question", "name": "Is tesamorelin FDA-approved?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, but narrowly. Tesamorelin (marketed as Egrifta) is approved only for reducing excess visceral abdominal fat in people with HIV-associated lipodystrophy [PMID:23657561]. Any other use is off-label. Research-chemical vials sold for laboratory use are not the approved drug product and are research-use-only." } }, { "@type": "Question", "name": "How much did the tesamorelin trials use?", "acceptedAnswer": { "@type": "Answer", "text": "The pivotal HIV lipodystrophy trials and the approved label used 2 mg subcutaneously once daily [PMID:18057338][PMID:20554713]. The 12-month liver-fat (NAFLD) study also used 2 mg/day [PMID:31611038]. The cognition trials in older adults used a lower 1 mg/day for 20 weeks [PMID:22869065]. These are study and label facts, not dosing recommendations for any other use." } }, { "@type": "Question", "name": "How is tesamorelin different from CJC-1295?", "acceptedAnswer": { "@type": "Answer", "text": "Both are GHRH analogs that stimulate the pituitary to release your own growth hormone. The practical differences are duration and evidence. Tesamorelin is a stabilized GHRH(1-44) dosed once daily, while CJC-1295 is a shorter GHRH(1-29) fragment whose DAC version binds albumin for a much longer half-life. Tesamorelin is the only GHRH analog with FDA approval and human RCT efficacy data; CJC-1295 has neither." } }, { "@type": "Question", "name": "Does tesamorelin actually reduce belly fat?", "acceptedAnswer": { "@type": "Answer", "text": "In HIV-associated lipodystrophy, yes, that is the approved and studied effect. Phase 3 trials showed roughly 15-18% reduction in visceral adipose tissue on 2 mg/day [PMID:18057338][PMID:20554713]. Two caveats: it targets visceral fat specifically and largely spares subcutaneous fat [PMID:21668043], and the effect reverses when you stop, so visceral fat re-accumulates off-drug [PMID:18690162]." } }, { "@type": "Question", "name": "Can tesamorelin improve cognition?", "acceptedAnswer": { "@type": "Answer", "text": "The human data are promising but early. A 20-week RCT in 152 older adults found GHRH favorably affected cognition, especially executive function, in both healthy adults and those with mild cognitive impairment [PMID:22869065], and a substudy showed it raised brain GABA and lowered myo-inositol [PMID:23689947]. This is a research signal from small, short trials. It is not an approved use and does not show tesamorelin prevents or treats dementia." } }, { "@type": "Question", "name": "What are the side effects of tesamorelin?", "acceptedAnswer": { "@type": "Answer", "text": "Trial-documented adverse events include injection-site reactions, joint pain (arthralgia), muscle aches, fluid retention and peripheral edema, tingling or numbness (paresthesia), and headache [PMID:21668043][PMID:20554713]. Because it raises IGF-1, it is contraindicated in active malignancy, in pituitary-axis disruption, and in pregnancy, and IGF-1 is typically monitored [PMID:21668043]. People with prediabetes or diabetes warrant glucose monitoring even though group-level glucose changes were not clinically meaningful in the trials." } }, { "@type": "Question", "name": "Does tesamorelin raise IGF-1?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, that is its intended mechanism. In the HIV trials, 2 mg/day raised mean IGF-1 by roughly 81-108% while keeping levels within or near the physiologic range [PMID:18057338][PMID:20554713]. In the cognition trial, 1 mg/day raised IGF-1 by 117% [PMID:22869065]. Elevated IGF-1 is both the therapeutic effect and the primary safety watch-item." } }, { "@type": "Question", "name": "How should research tesamorelin be stored and reconstituted?", "acceptedAnswer": { "@type": "Answer", "text": "Research tesamorelin ships as a lyophilized powder. It is reconstituted with bacteriostatic or sterile water and, once mixed, kept refrigerated (about 2-8C) and protected from light. Unreconstituted powder is more stable but still best kept cool. See the reconstitution guide and storage guide for research handling. This is descriptive of research practice, not an endorsement of non-prescription use." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, vendor price comparisons, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. We earn a commission on purchases through some of our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" } ] --- [Skip to content](#main-content) ## Research Use Only This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. We rank every vendor on the same public methodology, and we earn a commission on purchases through some of our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy). I'm 21+, enter siteLeave site [![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/) [Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools) Learn Community Search ⌘K [Sign In](/auth?returnTo=%2Fblog%2Ftesamorelin-research-guide) Compare notes with other researchers. Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 1. [Home](/) 3. [Blog](/blog) 5. Tesamorelin: A Complete Research Reference ![Tesamorelin: A Complete Research Reference](https://www.bodyhackguide.co/og-image.png) Peptides 12 min read Jul 1, 2026 Updated Sep 19, 2026 [Fact-checked](/editorial-standards "Read our editorial standards") # Tesamorelin: A Complete Research Reference Tesamorelin is a synthetic, stabilized GHRH analog approved as Egrifta for HIV-associated visceral fat. This guide covers the real trial evidence for visceral fat, liver fat, and cognition, how it differs from CJC-1295 and from GH itself, the approved and studied doses, and how the peptide-research community discusses it, with research-use-only framing throughout. B BioChonch Founder, BodyHackGuide Key Takeaway Tesamorelin is a synthetic, stabilized GHRH analog approved as Egrifta for HIV-associated visceral fat. This guide covers the real trial evidence for visceral fat, liver fat, and cognition, how it differs from CJC-1295 and from GH itself, the approved and studied doses, and how the peptide-research community discusses it, with research-use-only framing throughout. tesamorelin is a synthetic, stabilized copy of growth-hormone-releasing hormone (GHRH). It tells your pituitary to make and release more of your own growth hormone, which then raises IGF-1. It is FDA-approved as Egrifta for one narrow use: reducing excess visceral belly fat in HIV-associated lipodystrophy. Key Takeaway Tesamorelin is a GHRH(1-44) analog that stimulates the pituitary to release endogenous growth hormone rather than delivering GH directly. Its only approved indication is HIV-associated lipodystrophy visceral fat, where 2 mg/day cut visceral adipose tissue about 15% in phase 3 trials [PMID: 18057338](https://pubmed.ncbi.nlm.nih.gov/18057338 "PubMed ID: 18057338"). Everything else, including the interesting cognition data in older adults [PMID: 22869065](https://pubmed.ncbi.nlm.nih.gov/22869065 "PubMed ID: 22869065"), is research-stage. Research-chemical vials are not the approved drug and are research-use-only. This is education, not medical advice. ## What Tesamorelin Actually Is Tesamorelin is a stabilized analog of human GHRH (the 1-44 sequence). It binds the GHRH receptor on the anterior pituitary and prompts the synthesis and pulsatile release of your own growth hormone, which raises circulating IGF-1. That mechanism is well established in the endocrine literature [PMID: 21668043](https://pubmed.ncbi.nlm.nih.gov/21668043 "PubMed ID: 21668043")[PMID: 23657561](https://pubmed.ncbi.nlm.nih.gov/23657561 "PubMed ID: 23657561"). The "stabilized" part matters. Native GHRH gets chewed up fast by enzymes. Tesamorelin carries an added N-terminal modification that slows that degradation and extends the half-life enough to make once-daily dosing practical [PMID: 21668043](https://pubmed.ncbi.nlm.nih.gov/21668043 "PubMed ID: 21668043"). Because it works one step upstream of the pituitary, tesamorelin keeps your body's own feedback loop intact. Somatostatin can still throttle GH when levels get high, so you get a pulse that looks closer to natural physiology than a flat exogenous dose would. In the pivotal HIV trials, 2 mg/day raised mean IGF-1 by roughly 81-108% while keeping it within or near the physiologic range [PMID: 18057338](https://pubmed.ncbi.nlm.nih.gov/18057338 "PubMed ID: 18057338")[PMID: 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713 "PubMed ID: 20554713"). ## The Visceral Fat Evidence (The Approved Use) This is the part with real human RCT data behind it. Egrifta is approved specifically to reduce excess visceral abdominal fat in people with HIV-associated lipodystrophy, and that approval rests on solid phase 3 work. In the pivotal NEJM trial, 412 HIV patients with abdominal fat accumulation got 2 mg subcutaneously daily or placebo for 26 weeks. Visceral adipose tissue (VAT) dropped 15.2% on tesamorelin versus a 5.0% rise on placebo, triglycerides fell about 50 mg/dL, the total-cholesterol/HDL ratio improved, and IGF-1 rose 81% [PMID: 18057338](https://pubmed.ncbi.nlm.nih.gov/18057338 "PubMed ID: 18057338"). A pooled analysis of two phase 3 trials (806 patients) put the treatment effect at -15.4% VAT at week 26, with lipids and body image improving and subcutaneous fat preserved [PMID: 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713 "PubMed ID: 20554713"). Two findings stand out for anyone trying to understand this compound honestly. First, the benefit tracks with the fat loss: patients who lost more visceral fat (>=8% responders) had better triglyceride, adiponectin, and glucose outcomes than non-responders [PMID: 22495074](https://pubmed.ncbi.nlm.nih.gov/22495074 "PubMed ID: 22495074"). Second, and this is the one people skip, the effect is not permanent. When tesamorelin was stopped, visceral fat re-accumulated [PMID: 18690162](https://pubmed.ncbi.nlm.nih.gov/18690162 "PubMed ID: 18690162"). It behaves like a maintenance therapy, not a one-time reset. There is also a liver-fat signal. In an RCT of 61 people with HIV and non-alcoholic fatty liver disease, 2 mg/day for 12 months cut hepatic fat fraction by about 37% relative, and 35% of the tesamorelin group reached a liver fat below 5% versus 4% on placebo, with no glucose worsening between groups [PMID: 31611038](https://pubmed.ncbi.nlm.nih.gov/31611038 "PubMed ID: 31611038"). ## The Cognition and Aging Signal There is genuine human research here, and it is more interesting than most peptide "nootropic" claims, but it is early. A randomized, double-blind, placebo-controlled trial gave 152 older adults (ages 55-87, 66 with mild cognitive impairment) tesamorelin 1 mg/day for 20 weeks. GHRH favorably affected cognition (intent-to-treat P=.03, completers P=.002), with the benefit landing on executive function and a verbal-memory trend, in both healthy older adults and the MCI group. IGF-1 rose 117% and body fat dropped 7.4% [PMID: 22869065](https://pubmed.ncbi.nlm.nih.gov/22869065 "PubMed ID: 22869065"). A magnetic-resonance-spectroscopy substudy of 30 of those participants gives a plausible mechanism. Twenty weeks of tesamorelin raised brain GABA across three regions, raised NAAG in the frontal cortex, and lowered myo-inositol (an Alzheimer-linked osmolyte) in the posterior cingulate. The change in IGF-1 correlated with the change in GABA, which is early human evidence that GHRH nudges inhibitory neurotransmitters [PMID: 23689947](https://pubmed.ncbi.nlm.nih.gov/23689947 "PubMed ID: 23689947"). A separate exploratory analysis of the same trial found neuronal exosome biomarkers (synaptophysin, synaptotagmin) could moderately distinguish treated from placebo MCI patients, though that is a biomarker hint, not proof of clinical benefit [PMID: 30372675](https://pubmed.ncbi.nlm.nih.gov/30372675 "PubMed ID: 30372675"). Read this signal for what it is: small trials, 20 weeks, promising, not established. It is not approved, and it does not show tesamorelin prevents or treats dementia. ## Tesamorelin vs CJC-1295 vs GH People constantly confuse these three. Here is the clean version. Tesamorelin CJC-1295 Growth Hormone (somatropin) What it is Stabilized GHRH(1-44) analog GHRH(1-29) fragment; DAC and no-DAC versions The GH hormone itself, given exogenously Mechanism Stimulates pituitary to release your own GH Stimulates pituitary to release your own GH Bypasses the pituitary entirely Feedback intact? Yes (somatostatin still regulates) Yes No Typical dosing Once daily DAC: infrequent (albumin-bound, long half-life); no-DAC: short-acting Daily or more FDA approval Yes (Egrifta, HIV lipodystrophy) None Yes (multiple indications) Human RCT efficacy data Strong (visceral fat, cognition) Limited Extensive The key line: tesamorelin and CJC-1295 are both GHRH analogs, same receptor, same "stimulate the pituitary" logic. Tesamorelin is the only GHRH analog with FDA approval and human RCT efficacy data. CJC-1295 has neither. GH is a different category entirely, because it is the hormone itself and it overrides the feedback system that tesamorelin and CJC-1295 leave in place. ## How It Is Dosed: Studied Doses and Community Practice Reported as fact: the FDA-approved Egrifta dose for HIV-associated lipodystrophy is 2 mg subcutaneously once daily, injected into the abdomen, and that is the only approved use [PMID: 18057338](https://pubmed.ncbi.nlm.nih.gov/18057338 "PubMed ID: 18057338")[PMID: 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713 "PubMed ID: 20554713"). The visceral-fat phase 3 trials used exactly that, 2 mg/day for 26 weeks extended to 52, producing roughly 15-18% VAT reduction maintained only while dosing continued [PMID: 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713 "PubMed ID: 20554713")[PMID: 18690162](https://pubmed.ncbi.nlm.nih.gov/18690162 "PubMed ID: 18690162"). The 12-month NAFLD study used the same 2 mg/day [PMID: 31611038](https://pubmed.ncbi.nlm.nih.gov/31611038 "PubMed ID: 31611038"). The cognition trials used a lower 1 mg/day, self-administered about 30 minutes before bedtime, for 20 weeks [PMID: 22869065](https://pubmed.ncbi.nlm.nih.gov/22869065 "PubMed ID: 22869065")[PMID: 23689947](https://pubmed.ncbi.nlm.nih.gov/23689947 "PubMed ID: 23689947"). Now the community side, described so you understand the conversation, not as instructions. Everything in this block is anecdotal, unvalidated research-community folklore, not validated medicine. Research peptide is research-use-only. In peptide and bodybuilding forums, tesamorelin gets discussed mainly as a targeted "stubborn belly fat" peptide, and secondarily for GH-adjacent perks like sleep and recovery. Commonly described practice mirrors the label: around 2 mg subcutaneously once daily into the abdomen, usually at night to line up with the natural nocturnal GH pulse. Some reports describe lower daily amounts (around 1 mg) or 5-on/2-off style cycling to manage cost and side effects. Injecting on an empty stomach is a repeated talking point on the theory that an insulin or somatostatin spike blunts GH release, but that is a mechanistic hypothesis popular in forums, not a proven requirement for tesamorelin specifically. None of this is trial-validated. On the community's own comparison threads: tesamorelin is generally framed as the FDA-approved, visceral-fat-specific, once-daily option with real human data, while CJC-1295 (especially the DAC version) gets described as a cheaper, longer-acting "lifestyle" GH-support peptide often stacked with a ghrelin mimetic like ipamorelin for sleep and recovery. Forum users frequently note tesamorelin has the strongest evidence base of the GHRH analogs, which matches the literature. ## Safety, IGF-1, and the Honest Caveats Tesamorelin is a prescription drug approved only for HIV-associated lipodystrophy. Any other use, and any use of gray-market research peptide, is off-label or research-use-only and belongs in a conversation with a qualified clinician. Trial-documented adverse events include injection-site reactions, arthralgia (joint pain), myalgia, peripheral edema and fluid retention, paresthesia (tingling, sometimes carpal-tunnel-like), and headache [PMID: 21668043](https://pubmed.ncbi.nlm.nih.gov/21668043 "PubMed ID: 21668043")[PMID: 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713 "PubMed ID: 20554713"). Community reports mirror that list closely, and describe results as slow, usually over a couple of months, and reversing after stopping, which lines up with the trial finding that VAT re-accumulates off-drug [PMID: 18690162](https://pubmed.ncbi.nlm.nih.gov/18690162 "PubMed ID: 18690162"). On glucose: across the HIV trials, tesamorelin did not cause clinically meaningful changes in glucose or HbA1c at the group level [PMID: 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713 "PubMed ID: 20554713")[PMID: 31611038](https://pubmed.ncbi.nlm.nih.gov/31611038 "PubMed ID: 31611038"). But it raises GH and IGF-1, which can reduce insulin sensitivity, so anyone with prediabetes or diabetes warrants glucose monitoring, and responder data show glucose homeostasis held up better in those who lost more visceral fat [PMID: 22495074](https://pubmed.ncbi.nlm.nih.gov/22495074 "PubMed ID: 22495074"). IGF-1 elevation is the intended effect and the main watch-item. Elevated IGF-1 is a theoretical growth-promoting concern; tesamorelin is contraindicated in active malignancy, in disruption of the hypothalamic-pituitary axis (pituitary tumor, surgery, radiation, head trauma), and should be avoided in pregnancy. IGF-1 is typically monitored, with dose reduction or discontinuation if it runs too high [PMID: 21668043](https://pubmed.ncbi.nlm.nih.gov/21668043 "PubMed ID: 21668043"). ## Lab Handling for Research Material This is descriptive of research practice, not an endorsement of non-prescription use. Tesamorelin ships as a lyophilized (freeze-dried) powder. It gets reconstituted with bacteriostatic or sterile water, and once reconstituted it needs to stay cold, refrigerated at roughly 2-8C, and protected from light. Unreconstituted powder is more stable but is still best kept cool. If you are handling research material, the two guides worth reading first are the [complete peptide reconstitution guide](/blog/complete-peptide-reconstitution-guide-2026) and the [peptide storage guide](/blog/peptide-storage-guide). Community discussion widely acknowledges that most non-prescription "tesamorelin" is gray-market peptide of unverified purity, which makes third-party testing non-optional. Learn to [read a peptide COA](/blog/how-to-read-peptide-coa) and check [vendor scorecards](/vendors/scorecard) before trusting any lot. ## Where To Get Research-Grade Tesamorelin If you are sourcing research material, buy from a vendor that publishes a certificate of analysis per lot and makes it easy to verify. One option we feature is **[BHG Labs BH-Morelin 10mg](https://bhglabs.co/product/bh-morelin-10mg/?ref=zmgqyxku&coupon=BHG20)**, currently in stock, with COA-per-lot testing. Reader code **BHG20** takes 20% off. Treat it as one reputable COA-backed option among several, not the only one. Verify the COA yourself and compare against the [vendor scorecard](/vendors/scorecard) before you buy. For more on the compound and how it stacks, see the [tesamorelin compound page](/compound/tesamorelin) and the [retatrutide + tesamorelin shred stack protocol](/blog/ultimate-shred-stack-retatrutide-tesamorelin-protocol). ## Frequently asked What is tesamorelin and what is it researched for? Tesamorelin is a synthetic, stabilized analog of growth-hormone-releasing hormone (GHRH). It binds the GHRH receptor on the pituitary and stimulates release of your own growth hormone, which raises IGF-1 \[PMID:21668043\]. It is FDA-approved as Egrifta to reduce excess visceral abdominal fat in HIV-associated lipodystrophy \[PMID:18057338\], and it is being researched for broader visceral-fat and body-composition effects, liver fat \[PMID:31611038\], and cognition in older adults \[PMID:22869065\]. Is tesamorelin FDA-approved? How much did the tesamorelin trials use? How is tesamorelin different from CJC-1295? Does tesamorelin actually reduce belly fat? Can tesamorelin improve cognition? What are the side effects of tesamorelin? Does tesamorelin raise IGF-1? How should research tesamorelin be stored and reconstituted? Share this article: [𝕏 / Twitter](https://twitter.com/intent/tweet?text=Tesamorelin%3A%20A%20Complete%20Research%20Reference&url=https%3A%2F%2Fwww.bodyhackguide.co%2Fblog%2Ftesamorelin-research-guide) B [BioChonch](/about)Founder & Lead Researcher Founder, BodyHackGuide [](https://reddit.com/r/bodyhackguide)[](https://discord.gg/Mhq5UdRYBA)| [About the author](/about) ## Discussion Sign in to join the discussion [Sign In](/auth?returnTo=%2Fblog%2Ftesamorelin-research-guide) No comments yet. Be the first to share your thoughts! ## Price drops and new research New guides, price-drop alerts, and reader-submitted protocols. Unsubscribe anytime. Email addressSubscribe No spam. Unsubscribe anytime. ## Related Articles [ 💪 Peptides ### BPC-157 Protocol Guide 2026: Dosing, Reconstitution, Cycling & 10 PubMed Studies Read ](/blog/bpc-157-protocol-guide-2026)[ 🧬 Peptides ### Bacteriostatic Water vs a Finished Nasal Spray Base Read ](/blog/bacteriostatic-water-vs-finished-nasal-spray-base)[ 🧬 Peptides ### The Best Peptide Nasal Sprays of 2026, Ranked by Evidence Read ](/blog/best-peptide-nasal-sprays-2026) [Back to all articles](/blog) On this page [What Tesamorelin Actually Is](#what-tesamorelin-actually-is)[The Visceral Fat Evidence (The Approved Use)](#the-visceral-fat-evidence-the-approved-use)[The Cognition and Aging Signal](#the-cognition-and-aging-signal)[Tesamorelin vs CJC-1295 vs GH](#tesamorelin-vs-cjc-1295-vs-gh)[How It Is Dosed: Studied Doses and Community Practice](#how-it-is-dosed-studied-doses-and-community-practice)[Safety, IGF-1, and the Honest Caveats](#safety-igf-1-and-the-honest-caveats)[Lab Handling for Research Material](#lab-handling-for-research-material)[Where To Get Research-Grade Tesamorelin](#where-to-get-research-grade-tesamorelin)[Frequently Asked Questions](#frequently-asked-questions)[What is tesamorelin and what is it researched for?](#what-is-tesamorelin-and-what-is-it-researched-for)[Is tesamorelin FDA-approved?](#is-tesamorelin-fda-approved)[How much did the tesamorelin trials use?](#how-much-did-the-tesamorelin-trials-use)[How is tesamorelin different from CJC-1295?](#how-is-tesamorelin-different-from-cjc-1295)[Does tesamorelin actually reduce belly fat?](#does-tesamorelin-actually-reduce-belly-fat)[Can tesamorelin improve cognition?](#can-tesamorelin-improve-cognition)[What are the side effects of tesamorelin?](#what-are-the-side-effects-of-tesamorelin)[Does tesamorelin raise IGF-1?](#does-tesamorelin-raise-igf-1)[How should research tesamorelin be stored and reconstituted?](#how-should-research-tesamorelin-be-stored-and-reconstituted) Contents ## Shop BHG Labs Third-party tested with a certificate published per lot, batch-traceable, ships from the USA. 20% off your first order with code BHG20 , applied automatically at checkout. [Shop BHG Labs](https://bhglabs.co/shop/?utm_source=bodyhackguide&utm_medium=referral&utm_campaign=bhg20_site&utm_content=article&ref=zmgqyxku&coupon=BHG20) We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and no vendor can pay for a better placement. ![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews. [support@bodyhackguide.co](mailto:support@bodyhackguide.co) [](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide) Explore #### Explore - [Compare prices](/compare) - [Research suppliers](/vendors) - [Deals](/deals) - [Coupons](/coupons) - [Nootropics](/nootropics) - [Brain health](/brain-health) - [Blog](/blog) - [Guides](/guides) Tools #### Tools - [Reconstitution](/tools/reconstitution) - [Half-life visualizer](/tools/halflife) - [COA lookup](/tools/coa) - [Cost calculator](/tools/cost-calculator) - [Stack builder](/stack-builder) - [All tools →](/tools) Trust & vendors #### Trust & vendors - [Vendor directory](/vendors) - [Trust scorecard](/vendors/scorecard) - [Vendor trust badge](/vendors/get-vetted) - [Scoring methodology](/vendors/methodology) - [Peptide cheatsheet](/guides/peptide-cheat-sheet-download) Company #### Company - [About](/about) - [Affiliate disclosure](/affiliate-disclosure) - [Editorial standards](/editorial-standards) - [Creators](/creators) - [Coaches](/coaches) - [Privacy](/privacy) - [Terms](/terms) - [Full site directory →](/site-directory) **Affiliate Disclosure:** We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy) [Shop BHG Labs · 20% off with BHG20](https://bhglabs.co/shop/?utm_source=bodyhackguide&utm_medium=referral&utm_campaign=bhg20_site&utm_content=sticky_mobile_bar&ref=zmgqyxku&coupon=BHG20) hi 👋